These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 31200832)

  • 1. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
    Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
    Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
    Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
    Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
    Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
    J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
    Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
    Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer.
    Drake JA; Portnoy DC; Tauer K; Weksler B
    Ann Thorac Surg; 2018 Oct; 106(4):959-965. PubMed ID: 29856974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall.
    Drake JA; Sullivan JL; Weksler B
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1794-1802. PubMed ID: 29352585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
    J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer.
    Zhai X; Yang L; Chen S; Zheng Q; Wang Z
    Cancer Med; 2016 Sep; 5(9):2286-93. PubMed ID: 27367482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
    Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():784289. PubMed ID: 35155190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
    Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
    Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity-matched analysis in a cohort of 147 recurrences.
    Xu F; Chen HC; Xu H; Li J; Hao X; Xing P; Ying J; Wang Y
    Thorac Cancer; 2022 Nov; 13(22):3105-3113. PubMed ID: 36104006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer.
    Zhai W; Duan F; Li D; Yan Q; Dai S; Zhang B; Wang J
    Eur J Surg Oncol; 2022 Apr; 48(4):752-760. PubMed ID: 34620508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer.
    Francis S; Orton A; Stoddard G; Tao R; Hitchcock YJ; Akerley W; Kokeny KE
    J Clin Oncol; 2018 Feb; 36(4):333-341. PubMed ID: 29236592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection.
    Hu X; Chirovsky D; Walker MS; Wang Y; Kaushiva A; Tepsick J; Samkari A
    BMC Pulm Med; 2024 Jul; 24(1):332. PubMed ID: 38987763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.
    Bradbury P; Sivajohanathan D; Chan A; Kulkarni S; Ung Y; Ellis PM
    Clin Lung Cancer; 2017 May; 18(3):259-273.e8. PubMed ID: 28162945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.